Bluebird bio Inc (BLUE) — Cash Flow-to-Debt Ratio
Bluebird bio Inc (BLUE) has a Cash Flow-to-Debt Ratio of -0.12x as of March 2025, meaning its operating cash flow of $-43.44 Million could theoretically repay 0% of its total liabilities ($353.82 Million) in one year. See Bluebird bio Inc (BLUE) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bluebird bio Inc Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Bluebird bio Inc across 14 annual periods. Also explore BLUE year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bluebird bio Inc (2011–2024)
Year-by-year debt coverage analysis for Bluebird bio Inc. For market capitalisation and broader financial context, see Bluebird bio Inc (BLUE) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.53x | $-260.02 Million | $491.77 Million | ▲ +4.5% |
| 2023 | -0.55x | $-235.05 Million | $424.62 Million | ▲ +43.8% |
| 2022 | -0.98x | $-352.95 Million | $358.56 Million | ▲ +66.0% |
| 2021 | -2.90x | $-635.64 Million | $219.52 Million | ▼ -162.4% |
| 2020 | -1.10x | $-470.35 Million | $426.20 Million | ▲ +13.5% |
| 2019 | -1.28x | $-564.38 Million | $442.43 Million | ▼ -10.4% |
| 2018 | -1.16x | $-413.43 Million | $357.77 Million | ▼ -14.1% |
| 2017 | -1.01x | $-280.55 Million | $277.13 Million | ▼ -32.7% |
| 2016 | -0.76x | $-189.65 Million | $248.68 Million | ▼ -17.6% |
| 2015 | -0.65x | $-98.43 Million | $151.84 Million | ▲ +28.9% |
| 2014 | -0.91x | $-59.69 Million | $65.48 Million | ▼ -252.6% |
| 2013 | 0.60x | $43.45 Million | $72.72 Million | ▲ +455.1% |
| 2012 | -0.17x | $-21.04 Million | $125.07 Million | ▼ -19.3% |
| 2011 | -0.14x | $-12.22 Million | $86.62 Million | — |